Name of the Project
Influenza vaccine manufacturing facility.
Location
The facility will be located on the premises of Denka Seiken’s Niigata plant, in Gosen City, Niigata Prefecture, in Japan.
Client
Denka Seiken Co, a subsidiary of Denka Company.
Project Description
The project entails the construction of a new six-storey 2 226 m2 manufacturing facility to produce influenza vaccination bulk materials production lines and tetanus toxoid manufacturing lines, as well as quality control and other facilities.
The project will double the capacity of the existing vaccine bulk materials production facilities.
Potential Job Creation
None stated.
Value
¥16-billion.
Duration
The facility is expected to start operation in 2020.
Latest Developments
JGC Corporation has been awarded a lump-sum contract for the engineering, procurement and construction (EPC) of the project.
Key Contracts and Suppliers
JGC Corporation (EPC).
On Budget and on Time?
Too early to state.
Contact Details for Project Information
Denka Company, tel +81 3 5290 5511.